Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

PharmaTher Holdings Ltd

PHRM
Current price
0.25 CAD +0.000000000069 CAD (+0.00%)
Last closed 0.25 CAD
ISIN unknown
Sector Healthcare
Industry Biotechnology
Exchange Canadian Securities Exchange
Capitalization 21 687 180 CAD
Yield for 12 month +68.97 %
1Y
3Y
5Y
10Y
15Y
PHRM
21.11.2021 - 28.11.2021

PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's product pipeline includes KETARX, a ketamine hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain, and anesthesia and procedural sedation. It develops KETARX, a microneedle patch, for mental health, neurological, and pain disorders; and KETARX On-body pump for the maintenance of general anesthesia for diagnostic and surgical procedures. In addition, the company offers PHARMAPATCH, a microneedle patch technology solution, which includes hydrogel-forming and gelatin methacryloyl delivery system for the treatment of psychedelics and infectious diseases. Further, it has license agreement with BioRAE, Inc. for the development and commercialization of a novel biocompatible and biodegradable gelatin methacryloyl microneedle; and the University of Kansas to develop and commercialize the intellectual property of ketamine to treat ALS; as well as holds a patent and know-how license agreement with The Queen's University of Belfast to develop and commercialize hydrogel-forming microneedle patch delivery technology. The company was incorporated in 2019 and is headquartered in Toronto, Canada. Address: 82 Richmond Street East, Toronto, ON, Canada, M5C 1P1

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

6.95 CAD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures PHRM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -3 043 368 CAD
Operating Margin TTM
PE Ratio
Return On Assets TTM -42.76 %
PEG Ratio
Return On Equity TTM -80.35 %
Wall Street Target Price 6.95 CAD
Revenue TTM
Book Value 0.026 CAD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.05 CAD
Diluted Eps TTM -0.05 CAD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics PHRM

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History PHRM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation PHRM

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -1.7075
Price Book MRQ 8.1454

Financials PHRM

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators PHRM

For 52 weeks

0.11 CAD 0.43 CAD
50 Day MA 0.25 CAD
Shares Short Prior Month 14 472
200 Day MA 0.24 CAD
Short Ratio 0.16
Shares Short 13 773
Short Percent 0.14 %